Livero Inc.
9245.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | ¥3,586,529 | ¥2,900,000 | ¥2,555,046 | ¥2,376,765 |
| % Growth | 23.7% | 13.5% | 7.5% | – |
| Cost of Goods Sold | ¥732,779 | ¥441,000 | ¥329,651 | ¥326,597 |
| Gross Profit | ¥2,853,750 | ¥2,460,493 | ¥2,225,395 | ¥2,050,168 |
| % Margin | 79.6% | 84.8% | 87.1% | 86.3% |
| R&D Expenses | ¥19,824 | ¥9,000 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥2,066,000 | ¥1,917,000 | ¥0 |
| SG&A Expenses | ¥2,378,585 | ¥2,281,000 | ¥2,147,000 | ¥1,690,000 |
| Sales & Mktg Exp. | ¥0 | ¥215,000 | ¥230,000 | ¥0 |
| Other Operating Expenses | ¥1 | -¥9,000 | ¥533 | ¥571 |
| Operating Expenses | ¥2,398,410 | ¥2,281,000 | ¥2,147,533 | ¥1,690,571 |
| Operating Income | ¥455,340 | ¥178,000 | ¥77,861 | ¥359,596 |
| % Margin | 12.7% | 6.1% | 3% | 15.1% |
| Other Income/Exp. Net | ¥19,127 | -¥38,446 | ¥121 | -¥13,606 |
| Pre-Tax Income | ¥474,467 | ¥139,554 | ¥77,982 | ¥345,990 |
| Tax Expense | ¥135,545 | ¥35,609 | ¥27,201 | ¥106,982 |
| Net Income | ¥338,921 | ¥103,944 | ¥50,781 | ¥239,008 |
| % Margin | 9.4% | 3.6% | 2% | 10.1% |
| EPS | 64.6 | 19.85 | 9.57 | 48.66 |
| % Growth | 225.4% | 107.4% | -80.3% | – |
| EPS Diluted | 59.14 | 18.44 | 8.74 | 43.03 |
| Weighted Avg Shares Out | 5,715 | 5,236 | 5,307 | 4,912 |
| Weighted Avg Shares Out Dil | 5,731 | 5,637 | 5,810 | 5,554 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥562 | ¥220 | ¥17 | ¥5,086 |
| Interest Expense | ¥563 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥58,470 | ¥38,476 | ¥33,942 | ¥21,447 |
| EBITDA | ¥533,500 | ¥178,029 | ¥111,923 | ¥381,044 |
| % Margin | 14.9% | 6.1% | 4.4% | 16% |